GlobalData on MSN6d
GSK CEO addresses declining trust in vaccines following Trump re-electionGSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
A live webcast of the fireside chat can be accessed under ... Innoviva’s royalty portfolio includes respiratory assets partnered with Glaxo Group Limited (“GSK”). Innoviva is entitled to receive ...
13d
The FTSE 100 closed down 59.98 points at 8159.63 as traders digest Chancellor Rachel Reeves's Budget today. Among the ...
Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...
14don MSN
The FTSE 100 index is set to remain under pressure, having fallen by 0.8% in yesterday’s session. Futures trading is pointing ...
The pharmaceutical giant reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance ...
manufactured by GSK, and Abrysvo, made by Pfizer. Earlier this year, the National Advisory Committee on Immunization ...
A £1 billion profits landmark for Next and strong trading at Standard Chartered today provided FTSE 100 cheer during another painful session for GSK investors. London’s top flight followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback